CIZ1 interacts with YAP and activates its transcriptional activity in hepatocellular carcinoma cells

YAP and TAZ Take Center Stage in Cancer

(2015) Kun Zhang et al.   BIOCHEMISTRY

miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells

(2015) T Higashi et al.   BRITISH JOURNAL OF CANCER

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

(2015) Fa-Xing Yu et al.   CELL

Cyclin-A-CDK2-mediated phosphorylation of CIZ1 blocks replisome formation and initiation of mammalian DNA replication

(2015) N. A. Copeland et al.   JOURNAL OF CELL SCIENCE

Proteostasis trumps YAP in colon cancer

(2015) Tony Avril et al.   Science Signaling

Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver

(2015) Xiaolei Li et al.   Oncotarget

Proteostasis trumps YAP in colon cancer

(2015) Tony Avril et al.   Science Signaling

Yes-Associated Protein Expression is a Predictive Marker for Recurrence of Hepatocellular Carcinoma after Liver Transplantation

(2015) Hua Li et al.   DIGESTIVE SURGERY

MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3′UTR

(2014) Yue Wang et al.   ACTA PHARMACOLOGICA SINICA

Hippo Pathway Key to Ploidy Checkpoint

(2014) Bin Zhao et al.   CELL

VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex

(2014) Wenjing Zhang et al.   CELL RESEARCH

YAP activation is an early event and a potential therapeutic target in liver cancer development

(2014) Andrea Perra et al.   JOURNAL OF HEPATOLOGY

CIZ1 promoted the growth and migration of gallbladder cancer cells

(2014) Dexiang Zhang et al.   TUMOR BIOLOGY

MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer

(2013) Lanlan Li et al.   FEBS LETTERS

Variant Ciz1 is a circulating biomarker for early-stage lung cancer

(2012) G. Higgins et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

SnapShot: The Hippo Signaling Pathway

(2011) Caroline Badouel et al.   CELL

MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties

(2010) Angela M. Liu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma

(2010) M Z Xu et al.   ONCOGENE

Mst Out and HCC In

(2009) Bin Zhao et al.   CANCER CELL

Wnt Signaling in Liver Cancer

(2008) Yutaka Takigawa et al.   CURRENT DRUG TARGETS